The PennZone

  • Home
  • Business
  • Health
  • Financial
  • Construction
  • Automotive
  • Technology
  • Arts
  • Books

Utah attempts to legalize placenta cell therapy
The PennZone/10266985

Trending...
  • New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
  • Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
  • Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
Parent's Guide to Cord Blood Foundation
Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

BROOKEVILLE, Md. - PennZone -- Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Parent's Guide to Cord Blood Foundation is a small non-profit in the biotech space. We are the first to break the story that the Utah state legislature did not realize what they were voting for when they passed Utah S.B. 199.

More on The PennZone
  • Hiclean Tools Releases HCX2100 Electric Pressure Washer
  • Bùng Nổ Ra Mắt, AALIVE Tung Gói Thưởng 68% và Dàn Game Thuần Việt Hấp Dẫn
  • ARCH Dental + Aesthetics Offers Free Consultations for New Patients
  • Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida
  • New Online Retailer Vroom Bikez Brings Electric Bikes and Scooters to Eco-Conscious Consumers

The FDA still considers unapproved stem cell therapies to be illegal, and when it comes to drug regulations, federal law takes supremacy. This is not the same as states ignoring federal law and legalizing recreational drugs. In the case of stem cell therapy, patients that receive unregulated products with insufficient oversight could suffer serious adverse events. The new law Utah S.B. 199 is going to trigger a showdown between the federal government and Utah. Doctors who administer therapy to patients under the new Utah law could be sued by the Dept. of Justice. At a bare minimum, we are calling for the state of Utah to establish oversight of this arena before patients are hurt.

Contact
Frances Verter, PhD
***@parentsguidecordblood.org


Source: Parent's Guide to Cord Blood Foundation

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • $8 Billion High-Margin National Gentlemen's Club Market Targeted by Acquisition Strategy Incorporating the Successful Peppermint Hippo™ Brand: $TRWD
  • Why Indian Game Development Companies Are Shaping the Future of Global Gaming
  • Cold Storage and Proof-of-Reserves: BTXSGG Launches Institutional-Grade Asset Protection for Filipino Traders
  • Why FIRE Enthusiasts Are Buying Businesses Instead of Just Saving Their Way to Freedom
  • All About bail Bonds Expands Presence to Serve Houston Families
  • Thousands to Ride to L.A. Children's Hospital This Halloween Night
  • Essential Living Support Opens First VA Medical Foster Home in Cheyenne, Wyoming
  • Six-Figure Chicks Book Series 96 Authors, 6 Volumes Published to Empower and Mentor Women Nationwide
  • LSC Destruction Launches Cutting-Edge Cryptocurrency Scanning to Hard Drive Destruction Services
  • $150 Million Financing Initiates N A S D A Q's First Tether Gold Treasury Combining the Stability of Physical Gold with Blockchain $AURE
  • Podcast for Midlife Women Entrepreneurs Celebrates 100th Episode with Rhea Lana's Founder and CEO
  • What If Help Could Come Before the Fall?
  • Talented Learning Unveils 2025 LMS Award Winners
  • OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
  • Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
  • Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
  • Dirty Verse: Unhinged Humor in Rhyme Unleashed
  • UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
  • SprintRay Retainers and DIBS AI Braces in Reading Improve Precision and Patient Experience
  • $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk

Popular on PennZone

  • Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
  • Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
  • Angel's Awesome Books Launches Softcover "Positive Affirmation Journal for Kids" New Lower Price
  • Lake Norman Philharmonic Free Concert Opens 2025-2026 Season
  • Rapid Auto Shipping Revolutionizes Pennsylvania Car Shipping with Affordable, Tech-Driven Solutions
  • SHAREHOLDER ALERT: Berger Montague Reminds C3.ai, Inc. (NYSE: AI) Investors of Class Action Lawsuit Deadline
  • Cornea and Refractive Surgeon Dr. Talia Shoshany Joins OCLI Vision in Connecticut
  • CCHR: Why Psychiatric Detainment and Drugging Cannot Deliver Public Safety
  • ASR Media Wins a 2025 Mid-Atlantic Emmy® Award
  • New Jersey Therapy & Life Coaching Launches "Four Paws, Big Hearts" Fundraiser for Canine Companions

Similar on PennZone

  • New You Smile Dental Implant Center Expands Office
  • Restoration Dental Introduces YOMI Robot for High-Precision Implant Surgery in Oklahoma
  • Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
  • Vesica Health Granted PLA Billing Code for AssureMDx
  • David White DDS Advances Implant Dentistry with New Technology Acquisition
  • $750 Million Market Projected to Reach $3.35 Billion; Huge Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression $NRXP
  • Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing
  • 'ChilCorp – Water' Builds Momentum After Being Named as a Qualified Team in $119M XPRIZE Water Scarcity Global Competition
  • FDA Approval of Suitability Petition on Preservative-Free Ketamine Drug Supports $40 Analyst Target; $3 Billion Suicidal Depression Market: $NRXP
  • Vesica Health Receives AUA Guideline Inclusion
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us